JGC
ATNM icon

J. Goldman & Co’s Actinium Pharmaceuticals ATNM Stock Holding History

J. Goldman & Co’s Portfolio ATNM Stock Details ATNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-13,500
Closed -$79.9K – 354
2023
Q3 		$79.9K Hold
13,500
– – ﹤0.01% 334
2023
Q2 		$100K Sell
13,500
-28,728
-68% -$244K 0.01% 341
2023
Q1 		$399K Sell
42,228
-37,880
-47% -$400K 0.02% 283
2022
Q4 		$853K Sell
80,108
-68,630
-46% -$696K 0.06% 235
2022
Q3 		$1.1M Buy
+148,738
New +$925K 0.08% 248
2020
Q4 		– Sell
-168,749
Closed -$1.64M – 370
2020
Q3 		$1.64M Buy
168,749
+97,069
+135% +$1.07M 0.15% 182
2020
Q2 		$756K Buy
+71,680
New +$543K 0.07% 206

Other funds holding ATNM

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BGIM
Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return